4//SEC Filing
Harrison Seth Loring 4
Accession 0000950170-23-030213
CIK 0001744659other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 5:48 PM ET
Size
5.2 KB
Accession
0000950170-23-030213
Insider Transaction Report
Form 4
Harrison Seth Loring
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-23+15,000→ 15,000 totalExercise: $50.83Exp: 2033-06-22→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]This option shall vest in full upon the earlier of (i) June 23, 2024 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001404955
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 5:48 PM ET
- Size
- 5.2 KB